With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Seasoned advisory group including RNA, translation and commercialisation luminaries.

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...

Drug discovery is a key area for AI, given the speed at which models trained on massive datasets can tackle a variety of tasks. Last year, Nvidia said it was doubling down on AI-powered drug discovery ...

We recently compiled a list of the 10 Best Quantum Computing Stocks to Buy for 2025. In this article, we are going to take a ...

The addition of Tavros greatly expands Vividion's functional genomics expertise and capabilities, bringing proprietary methods for genomic screening that can identify new target opportunities, as well ...

Finding new medicines has always been a long, expensive, and complicated process. Scientists need to identify the right targets in the body, test thousands of potential compounds, and spend years in ...